Skip to main content
. 2015 Jul 6;6(29):28194–28210. doi: 10.18632/oncotarget.4442

Table 1. Splenic immune cell subset changes in non-tumor bearing BALB/c mice after administration of MVA-TWIST/TRICOM.

CD4+ T cells CD8+ T cells Effector Memory CD8+ T cells Twist Tetramer+ CD8+ T cells Dendritic cells Activated Dendritic cells
No Treatment 26.10 (1.017) 10.92 (0.2853) 0.7470 (0.0473) 2.43 1.390 (0.1243) 0.2592 (0.0762)
MVA-TWIST/TRICOM 26.78 (0.5093) 12.22 (0.2131) 1.56 (0.1597)* 3.83* 1.410 (0.07629) 0.5564 (0.0702)*

Flow cytometric analysis of splenic immune cell subsets in BALB/c mice (n = 5/group). Animals were administered two weekly vaccinations with MVA-TWIST/TRICOM or left untreated. Spleens were harvested 17 days after the last vaccination. Data represented as “mean (SEM)” percentage of viable splenocytes. CD4+ T cells (CD3+ CD4+), CD8+ T cells (CD3+ CD8+), Effector Memory cells (CD3+CD8+CD44+CD62L-), Dendritic cells (CD11c+MHCII+) and Activated Dendritic cells (CD11c+MHCII+CD40+).

*

= p < 0.01 as determined by Student’s t test or the Kolmogorov-Smirnov test.